Abstract
Pancreatic cancer is one of the most common human cancers with very low survival rate. So far, the difficulties to make early diagnosis and find curative therapy for this malignant disease remain challenging. Considering Chinese medicine with a long history of clinical application in treating various human diseases, it has been now introduced into the anti-cancer treatment and begun to attract attentions of researchers worldwide. Here, we summarize the recent studies on the anti-tumor activity of Chinese medicine in human pancreatic cancer and the potential molecular mechanisms.
Keywords: Chinese medicine, pancreatic cancer, therapy.
Current Signal Transduction Therapy
Title:Chinese Medicine: A Novel Therapeutic Option for Pancreatic Cancer
Volume: 9 Issue: 1
Author(s): Ping Yan, Yongxing Cao and Xiaotian Sun
Affiliation:
Keywords: Chinese medicine, pancreatic cancer, therapy.
Abstract: Pancreatic cancer is one of the most common human cancers with very low survival rate. So far, the difficulties to make early diagnosis and find curative therapy for this malignant disease remain challenging. Considering Chinese medicine with a long history of clinical application in treating various human diseases, it has been now introduced into the anti-cancer treatment and begun to attract attentions of researchers worldwide. Here, we summarize the recent studies on the anti-tumor activity of Chinese medicine in human pancreatic cancer and the potential molecular mechanisms.
Export Options
About this article
Cite this article as:
Yan Ping, Cao Yongxing and Sun Xiaotian, Chinese Medicine: A Novel Therapeutic Option for Pancreatic Cancer, Current Signal Transduction Therapy 2014; 9 (1) . https://dx.doi.org/10.2174/157436240901140924103948
DOI https://dx.doi.org/10.2174/157436240901140924103948 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Fabrication of Poly Hydroxybutyrate-Polyethylene Glycol-Folic Acid Nanoparticles Loaded by Paclitaxel
Current Drug Delivery Synaptic Plasticity as a Therapeutic Target in the Treatment of Autism-related Single-gene Disorders
Current Pharmaceutical Design Targeting mTOR: Evaluating the Therapeutic Potential of Resveratrol for Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Optimizing Target Selection and Development Strategy in Cancer Treatment; The Next Wave
Current Medicinal Chemistry - Anti-Cancer Agents Neurokinin-1 Receptor (NK-1R) Antagonists: Potential Targets in the Treatment of Glioblastoma Multiforme
Current Medicinal Chemistry Application of Radiolabeled Antibodies in Targeting Therapy of Breast Cancer
Current Molecular Imaging (Discontinued) Liposomal Irinotecan in the Treatment of Refractory Pancreatic Cancer
Recent Patents on Anti-Cancer Drug Discovery RAN GTPase as a Target for Cancer Therapy: Ran Binding Proteins
Current Molecular Medicine QSAR and 3D-QSAR Models in the Field of Tubulin Inhibitors as Anticancer Agents
Current Topics in Medicinal Chemistry Survey of Functional Activities of Alpha-fetoprotein Derived Growth Inhibitory Peptides: Review and Prospects
Current Protein & Peptide Science Mesenchymal Stem Cells and Their Cell Surface Receptors
Current Rheumatology Reviews ChemoImmunoModulation: Immune Regulation by the Antineoplastic Chemotherapeutic Agents
Current Medicinal Chemistry Contribution of Major Polyphenols to the Antioxidant Profile and Cytotoxic Activity of Olive Leaves
Anti-Cancer Agents in Medicinal Chemistry New Target Therapies for Brain Metastases from Breast Cancer
Current Cancer Drug Targets Facile Synthesis of Hollow Mesoporous Hydroxyapatite Nanoparticles for Intracellular Bio-imaging
Current Nanoscience The Potential Use of RNA-based Therapeutics for Breast Cancer Treatment
Current Medicinal Chemistry A Novel Strategy for Preparing Glycopeptide Molecular Probe Using Fluorous Technology
Protein & Peptide Letters New Developments in the Management of Pleural Effusions
Current Respiratory Medicine Reviews Ultrasonic Elasticity Imaging as a Tool for Breast Cancer Diagnosis and Research
Current Medical Imaging CDKN2B-AS1: An Indispensable Long Non-coding RNA in Multiple Diseases
Current Pharmaceutical Design